Sign up to gain complete access to Medznat
Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Drug reactions and non-allergic triggers lead geriatric allergy r...
Geriatric allergy complaints frequently stem from non-allergic etiologies, drug hypersensitivities, and high comorbidity burdens rather than trad...
Transpedal genicular artery embolization eases chronic knee osteo...
In patients suffering from chronic knee osteoarthritis, transpedal genicular artery embolization shows sustained 6-month improvements in pain and...
Novel fusion protein LEVI-04 effectively reduces knee OA pain
LEVI-04, a new neurotrophin-3 inhibitor, is beneficial to improve pain and physical function in knee osteoarthritis while maintaining a favorable...
80% of geriatric patients receive polytherapy, study finds!
Four out of five geriatric outpatients experience polytherapy, which accounts for nearly all potential drug–drug interactions and fuels hig...
TNFi failure? Upadacitinib sustains psoriatic arthritis control f...
Upadacitinib 15 mg once daily sustains clinical and skin responses through 152 weeks in patients with psoriatic arthritis previously exposed to o...
Temperature-controlled sleep reduces menopausal hot flashes by 57...
Active nighttime temperature regulation reduces nocturnal hot flashes by 57% and improves sleep quality in menopausal women, regardless of hormon...
Ibuprofen vs. acetaminophen in children: New evidence on safety f...
Ibuprofen and acetaminophen show comparable short-term safety in children with acute pain.
Polyendocrine metabolic ovarian syndrome (PMOS): Is PCOS getting...
Polycystic ovary syndrome has beeen officially renamed to polyendocrine metabolic ovarian syndrome to reflect its complex multisystem pathophysio...
Ketorolac offers effective nonopioid analgesia for acute pain in...
Ketorolac provides analgesia comparable to opioids across multiple acute pain conditions in adults presenting to the emergency department.
2026 ESC/ERA guidelines strengthen integrated cardiovascular–kidn...
The 2026 ESC/ERA guidelines mandate early combined screening with SGLT2i and non-steroidal MRAs as Class I baseline therapies to stop cardio-rena...
RAPIDIRON trial analysis: Intravenous vs. oral iron for pregnancy...
Single-dose intravenous ferric carboxymaltose and ferric derisomaltose produce greater improvements in red cell and reticulocyte indices than ora...
Poor hemoglobin response to iron therapy linked to stillbirth ris...
Greater hemoglobin improvement at 20–24 weeks is associated with a lower risk of stillbirth, while hemoglobin below 10.5 g/dL is associated...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.
